Journal home
Advance online publication
Current issue
Archive
Press releases
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Immunology
Nature Medicine
Nature Cell Biology
NI Tutorial: Finding regulatory DNA regions
Signaling Gateway
Immunology & Cell Biology
Mucosal Immunology
Nature Conferences
Nature Stem Cells
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Review
Nature Immunology  4, 1057 - 1064 (2003)
Published online: 29 October 2003; | doi:10.1038/ni1001

Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling

Jesse E Jun & Christopher C Goodnow

Jesse E. Jun and Christopher C. Goodnow are at the Australian Cancer Research Foundation Genetics Laboratory and Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia.

Correspondence should be addressed to Christopher C Goodnow chris.goodnow@anu.edu.au
Lymphocyte antigen receptors are responsible for inducing the opposite responses of immunity or tolerance. How the correct polarity of antigen receptor signaling is encoded has been an enduring enigma. Here we summarize recent advances defining key scaffolding molecules, CARMA1 (also known as CARD11) and the Cbl family of ubiquitin ligases, required for either immunogenic or tolerogenic signaling by antigen receptors. These scaffolding proteins may determine the polarity of response to antigen by promoting assembly around antigen receptors of competing multiprotein signal complexes: immunosomes versus tolerosomes. Each of the factors that influence immunogenicity or tolerogenicity—stage of lymphocyte differentiation, concurrent engagement of inhibitory or costimulatory receptors, extent of receptor crosslinking, and prior antigen experience—may be integrated in lymphocytes through their capacity to influence the probability of assembling immunosomes versus tolerosomes.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

NEWS AND VIEWS
Vav and the B cell signalosome
Nature Immunology News and Views (01 Jun 2001)

RESEARCH
BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells
Oncogene Original Article (17 Apr 2003)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Immunology
ISSN: 1529-2908
EISSN: 1529-2916
Journal home | Advance online publication | Current issue | Archive | Press releases | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy